Treatment and prevention of coronary heart disease by lowering serum cholesterol levels; From the pioneer work of C. D. de Langen to the third 'Dutch Consensus on Cholesterol'

Acta Cardiologica

Volumn 54, Issue 3, 1999, Pages 163-168

  Jukema, J Wouter ^a   Simoons, Maarten L ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Cholesterol; Coronary artery disease; Guidelines; Prevention; Treatment

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; STATIN;

ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CIGARETTE SMOKING; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DISEASE COURSE; FAMILIAL HYPERCHOLESTEROLEMIA; HEART INFARCTION; HIGH RISK PATIENT; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; LIFE EXPECTANCY; LIPID DIET; NETHERLANDS; PRACTICE GUIDELINE; RISK MANAGEMENT; VASCULAR DISEASE; WEIGHT REDUCTION;

CHOLESTEROL; CORONARY DISEASE; DIET, FAT-RESTRICTED; HISTORY, 20TH CENTURY; HUMANS; HYPERCHOLESTEROLEMIA; RISK FACTORS;

EID: 0032774032     PISSN: 00015385     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (17)

1. Anitschkow N. Über die Veränderungen der Kaninchenaorta bei experimenteller Cholesterinsteatose (German). Beitrage zur pathologischen Anatomie und zur allgemeinen Pathologie 1913; 56: 379-404.
2. De Langen CD. Cholesterine-metabolism and pathology of races (English and Dutch). In: Mededeelingen van de burgerlijken geneeskundigen dienst in Nederlands-Indië 1918; 1-35.
3. Erkelens DW. Cholesterol-consensus in Nederland. (Cholesterol Consensus in the Netherlands (Dutch)) Ned Tijdschr Geneeskd 1987; 131: 1564-9.
4. Erkelens DW. Herziening consensus cholesterol. (Revised Cholesterol Consensus (Dutch)) Ned Tijdschr Geneeskd 1991; 131: 2337-40.
5. Simoons ML, Casparie AF. Behandeling en preventie van coronaire hartziekten door verlaging van de serumcholesterolconcentratie; derde consensus "Cholesterol". (Treatment and prevention of coronary heart disease by lowering of serum cholesterol; the third Cholesterol Consensus (Dutch)). Ned Tijdschr Geneeskd 1998; 142; 2096-101.
6. Jukema JW, Bruschke AVG, van Boven AJ, Reiber JHC, Bal ET, Zwinderman AH, Jansen H, Boerma GJ, van Rappard FM, Lie KI et al.. Effects of lipid lowering progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS). Circulation 1995; 91: 2528-40.
7. MAAS Investigators. Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS). Lancet 1994; 344: 63-8.
8. Vos J. Retardation of progression of coronary atherosclerosis [thesis]. Erasmus Universiteit, Rotterdam, 1997.
9. Truswell AS. Review of dietary intervention studies: effect on coronary events and on total mortality. Aust N Z J Med 1994; 24: 98-106.
10. Nader advies inzake de richtlijn m.b.t. de vetconsumptie uit het advies Richtlijn Goede Voeding 1986. (Further advice on the guideline regarding the consumption of fat from the Guidelines for a Healthy diet (Dutch)) Voedingsraad, Den Haag; Voorlichtingsbureau voor de Voeding, 1991.
11. Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4,444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.
12. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JM, Wun CC, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996; 335: 1001-9.
13. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
14. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW. McKillop JH, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 1995; 333: 1301-07.
15. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, Langendorfer A, Stein EA. Kruyer W, Gotto AM Jr. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS Air Force/Texas Coronary Atherosclerosis Prevention Study. JAMA 1998; 279 (20): 1615-22.
16. Law MR, Wald NJ, Thompson SG. By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease? BMJ 1994; 308: 367-73.
17. Grover SA, Coupai L, Hu XP. Identifying adults at increased risk of coronary disease. How well do the current cholesterol guidelines work? JAMA 1995; 274: 801-6.